MindMed to Report Q3 2025 Financial Results on November 6, 2025
NEW YORK — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it will host a live webcast at 4:30
(Financial Post, 2025-10-30T20:02:35Z)